U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 3-9, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 3-9, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 05/04/2020
Location: Pre-Recorded Video
Subject: United States Pharmacopeia Convention Meeting and 200th Anniversary
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, government, industry and other invited guests

Event Date: 05/04/2020
Location: Teleconference
Subject: COVID-19 Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of PhRMA (Pharmaceutical Research and Manufacturers of America)

Event Date: 05/05/2020
Location: Teleconference
Subject: Association of Public Health Laboratories: Serology Tests
FDA Participant/Group: TIMOTHY STENZEL; DAYLE CRISTINZIO; JEFFREY SHUREN; LAURA CALIGUIRI; KEAGAN LENIHAN;
Non FDA Participant/Group: Several board members and staff from the Association of Public Health Laboratories

Event Date: 05/06/2020
Location: Teleconference
Subject: Medical Technology Industry Efforts Against COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Deborah Birx (White House); Vincent Forlenza (Becton, Dickinson and Company); Scott Whitaker (AdvaMed);

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 05/07/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders

Event Date: 05/08/2020
Location: Virtual
Subject: CNS (Collaborating for Novel Solutions) Summit Community Call on Impact of COVID-19 Crisis on Clinical Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 05/05/2020
Location: Teleconference
Subject: COVID-19 Response
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: Liz Goodman, Matt Eyles (America's Health Insurance Plans (AHIP));

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/05/2020
Location: Virtual
Subject: Food Safety and Data Issues of Mutual Interest
FDA Participant/Group: CAITLIN BOON; CHARLES PASTEL; ANDREW KENNEDY; SARA MARRIE; KASEY HEINTZ; SUZANNE ROOSEN; NINA ZIMDAHL;
Non FDA Participant/Group: Don Lowery, Jay Dennis, Jeff Ritchie, Kristie Stegen (The Nielsen Company);

Event Date: 05/08/2020
Location: Virtual
Subject: Food Safety and Budget Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several Senate Agriculture Appropriations Sub-Committee staff members

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/04/2020
Location: Virtual
Subject: Medical Research During a Crisis
FDA Participant/Group: N/A
Non FDA Participant/Group: Jane F. Barlow (Real Endpoints); Bob Harmon, Mike Allen (Axios); Rep. Scott Peters (D-CA);

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

 

Back to Top